A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS速 Inhaler 250/50mcg Plus SPIRIVA HANDIHALER速 Inhaler Versus SPIRIVA HANDIHALER速 Inhaler Plus Placebo DISKUS速 Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).